Search

Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.

… Monday, May 15, 2023 This year 17 scientists who did their training at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) are poised to receive their doctorates, the highest number ever to graduate from GSK in a single year. Their years of dedication and training will be recognized

… Wednesday, February 11, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Maximilian Merz Awarded $2.3 Million From the Hector Foundation  Maximilian Merz Maximilian Merz, MD, mmyeloma specialist, has been  awarded $2.3 million by the Hector Foundation

Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.

… Thursday, October 24, 2019 Summary Scientists at the Sloan Kettering Institute have made a fundamental discovery about how dendritic cells in the immune system are organized into distinct types. The results could inform immunotherapy for cancer and other diseases. Biologists sometimes liken the immune

Memorial Sloan Kettering researchers will lead and present notable research at the American Association for Cancer Research (AACR) Virtual Annual Meeting II.

… Friday, June 19, 2020 Thousands of oncology experts from around the world will tune in virtually June 22-24 for the American Association for Cancer Research (AACR) Virtual Annual Meeting II . Memorial Sloan Kettering (MSK) researchers will lead and present some of the most notable research at the meeting

Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in such programs, driving the need for more accurate decision-making tools such as the 4Kscore test developed at Memorial Sloan Kettering.

… Thursday, October 12, 2017 Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in active surveillance programs, driving the need for more-accurate decision-making tools

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan Kettering Cancer Center.

… Wednesday, February 13, 2013 The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan Kettering Cancer Center. Published in the February

In order to preserve healthcare resources and provide exceptional care, our teams have been working together to develop new and innovative ways to treat our patients during the COVID-19 pandemic. MSK radiation oncologists rapidly re-evaluated our rectal cancer practice policies during this public health emergency.

… Friday, May 15, 2020 Cancer care is essential and should not be put on hold. Here at Memorial Sloan Kettering (MSK) we’ve put in place the strictest safety measures to ensure our patients continue to receive world-class cancer care in the safest environment possible. In order to preserve healthcare resources

Spinal cord compression due to spinal metastases is a medical emergency. Modern treatment approaches have fundamentally shifted the paradigm from providing short-term palliation and pain relief to delivering durable tumor control with fewer morbidities than older approaches. Therefore, cancer patients who have symptoms of spinal cord compression should be referred for surgical evaluation as soon as possible.

… Thursday, June 14, 2018 Spinal cord compression due to spinal metastases is a medical emergency. Modern treatment approaches — minimally invasive surgical techniques and spinal stereotactic radiosurgery (SSRS) — have fundamentally shifted the paradigm from providing short-term palliation and pain relief

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.

… Wednesday, November 15, 2017 Summary The FDA’s authorization of MSK-IMPACT sets a precedent for future authorization of tests developed by both academic and commercial labs. The US Food and Drug Administration has announced the authorization of MSK-IMPACT™ . The test was developed by Memorial Sloan Kettering

Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.

… Monday, February 8, 2021 Summary Researchers at Memorial Sloan Kettering in collaboration with scientists in Germany have discovered that an investigational cancer drug has powerful effects against SARS-CoV-2, the virus that causes COVID-19. An investigational cancer drug with roots in the Malaysian